补阳还五汤配合西药分期治疗急性高血压脑出血的疗效观察  

Buyang Huanwu decoction with western medicine in the treatment of acute hypertensive cerebral hemorrhage

作　　者：周文[1] 董美华[1] 孙西周 李洪朋 

机构地区：[1]山东省日照市中医医院神经外科,日照276800

出　　处：《陕西中医》2016年第8期971-973,共3页Shaanxi Journal of Traditional Chinese Medicine

摘　　要：目的:探讨急性高血压脑出血治疗中结合西医分期进行补阳还五汤辨证加减治疗的应用价值。方法:将80例急性高血压脑出血患者随机分为两组,对照组接受西医治疗,治疗组接受西医分期后补阳还五汤辨证加减治疗,每组40例。对比两组神经损伤及炎性因子变化情况。结果:两组治疗期间生存率比较无统计学差异(P>0.05)。在完成2周治疗后,治疗组格拉斯哥昏迷指数(GCS)评分高于对照组,而美国国立卫生研究院卒中量表(NIHSS)评分、超敏C反应蛋白(hs-CRP)、血管内皮生长因子(VEGF)及血小板抗原(Hpa)低于对照组(P<0.05)。治疗组治疗总有效率高于对照组(P>0.05),而不良反应发生率比较无统计学差异(P>0.05)。结论:结合西医分期进行补阳还五汤辨证加减治疗可有效的提高急性高血压脑出血的临床治疗效果。Objective ：To explore application value of Buyang Huanwu decoction with western medicine in the treatment of acute hypertensive cerebral hemorrhage .Methods ：80 cases of acute hypertensive cerebral hemorrhage pa-tients were random divided into two groups ,accepted western medicine as control group ,accepted Buyang Huanwu de-coction according to western medicine stage as treatment group ,40 in each group .Compared the nerve injury ,inflamma-tory factor changes of the two groups .Results ：There was no statistical difference of survival of two groups （P〉 0 .05） . After 2-week treatment ,the GCS score of treatment group was higher than control group ,the NIHSS score ,hs-CRP , VEGF and Hpa were lower than control group（P〈 0 .05） .The total effective of treatment group was higher than control group（P〉 0 .05） .There was no statistical difference of incidence of adverse reactions of two groups （P〉 0 .05） .Conclu-sion ：Buyang Huanwu decoction with western medicine treatment can effectively improve the clinical treatment effect of a -cute hypertensive cerebral hemorrhage .

关 键 词：脑出血/中西医结合疗法 补阳还五汤/治疗应用 

分 类 号：R743.34[医药卫生—神经病学与精神病学]